US President Donald Trump has signed an executive order that could impose tariffs of up to 100 percent on certain patented medicines if pharmaceutical companies fail to reach agreements with his administration in the coming months. Under Thursday’s order, companies that sign a “most favoured nation” pricing agreement and are actively investing in and building More